There is no single best moisturiser for everyone with facial eczema. Start with a bland, fragrance-free medical emollient and ask a pharmacist or clinician which format suits your skin and treatment plan. You do not need an expensive serum, a particular active ingredient or a headline percentage to make that choice.
This guide focuses on atopic eczema. Facial rashes can also involve contact dermatitis or other conditions, so an ingredient checklist cannot diagnose the cause. The National Eczema Society’s facial eczema guidance explains why diagnosis and careful product selection matter.
What to look for in a facial eczema moisturiser
Choose a format you can use comfortably
Emollients come as lotions, creams, gels and ointments. A light texture may be convenient during the day; a richer one may suit very dry skin. The NHS guide to emollients describes the options. A body-care label or a greasy feel alone does not establish that a product is unsuitable for the face. Check its directions and ask for advice about the area you want to treat.
Avoid treating a serum, cream or ointment as automatically better because of its format. The childhood trial discussed below found no difference in symptom control between four emollient types; it did not identify a winner for adult facial eczema.
Check fragrance and your known sensitivities
The National Eczema Society advises avoiding perfumed face creams and reducing irritation from cosmetics during active facial eczema. It also warns that labels such as natural, hypoallergenic and dermatologically tested do not rule out a reaction. Check the whole ingredient list against anything you have been advised to avoid.
Fragrance-free does not mean free of every possible allergen. Persistent facial symptoms may need assessment for contact allergy; choosing a product by its front label cannot replace that assessment.
Do not use an ingredient list as a treatment ranking
A ceramide name, a hyaluronic-acid molecular weight or a pH number cannot tell you how well a finished product will control eczema. Nor does the presence of allantoin, betaine or squalane establish wound healing, guaranteed tolerance or freedom from blocked pores. Look for evidence about the actual formula and the outcome claimed.
What the original ceramide studies show
Ceramides are part of the skin’s outer barrier lipids. In a 1991 study by Imokawa and colleagues, researchers measured lower ceramide levels in affected and unaffected forearm skin from people with atopic dermatitis than in age-matched controls. This was an observational study, not a moisturiser trial. It does not establish a universal 30% deficit or prove that adding particular ceramide types makes any cream an eczema treatment.
Treatment studies need a separate reading. In particular, an improvement in measured water loss is not the same outcome as an improvement in eczema symptoms. These trials illustrate the limits:
Scroll the table sideways to read each study and its limitations.
| Study and comparison | What was found | What it does not establish |
|---|---|---|
| Spada et al. (2021): 100 adults, 28 days. A ceramide-containing cream and cleanser regimen versus comparator products without several active ingredients. | Water loss and hydration measures favoured the active regimen. The primary eczema-severity outcome did not differ significantly between groups at day 28, nor did rescue-steroid use. | This tested a multi-ingredient regimen, not ceramides alone. It was manufacturer-sponsored; several authors were employees. It does not prove superiority for every ceramide product. |
| Gupta et al. (2023): 53 children. Ceramide-based versus paraffin-based moisturiser; the main comparison reported here was at three months. | Both groups improved. No significant difference in the change in eczema severity was detected between them. | The study did not meet its predefined test for equivalence. No detected difference does not prove the products identical. It was not a trial of adult facial eczema. |
| Ridd et al. (2022), BEE trial: 550 children aged six months to 12 years. Lotion, cream, gel or ointment, with symptoms assessed over 16 weeks. | No difference in parent-reported eczema severity was detected between the four types. | Parents and clinicians knew the assigned treatment. The result does not rank every brand or establish the best format for an adult’s face. |
The practical conclusion is to consider the whole formula, whether you can use it comfortably, and your treatment plan. These findings do not justify dismissing a simple paraffin-based emollient or treating a disclosed ceramide percentage as proof of better eczema control.
What about ectoin?
A 2014 trial by Marini and colleagues enrolled 65 adults with mild-to-moderate atopic dermatitis. It compared an ectoin-containing cream with another non-steroidal cream on two matching areas of eczema for 28 days. The authors reported comparable efficacy. This was evidence about those two formulas, not ectoin alone or The Mantle. The abstract does not provide every detail needed to judge the comparison, and it does not establish superiority over standard emollients.
Our ectoin guide separates ingredient research from claims about a finished serum. You do not need to seek out ectoin to follow an eczema treatment plan.
How to use an emollient alongside treatment
Follow your product and treatment instructions. The NHS advises smoothing emollient on gently, applying it after washing once skin has been patted dry, and using it regularly. Ask a pharmacist about a reaction or a product that does not suit you.
The NHS guidance advises a 20–30 minute gap between an emollient and another skin treatment, and says to ask a doctor which to apply first. Follow specific directions for your prescription; do not use moisturiser to change a medicine’s strength or absorption yourself.
If a prescribed treatment irritates, ask your prescriber or pharmacist what to do. Do not stop, restart or change its dose based on this guide. During active facial eczema, follow the National Eczema Society’s advice about avoiding irritating cosmetics rather than introducing exfoliants or cosmetic retinol.
When to seek medical advice
See a GP if you think you have eczema or treatment is not helping. The NHS advises urgent help if eczema becomes painful, hot, swollen, blistered, crusty or leaks fluid, worsens rapidly, or comes with fever or feeling unwell.
The Mantle and eczema evidence
We make The Mantle, a cosmetic serum. None of the studies above tested it, and its ingredient list does not establish that it treats eczema. For active facial eczema, seek advice about a medical emollient and your treatment plan rather than introducing a cosmetic serum as treatment.
Read The Mantle’s formula details
The Mantle is a fragrance-free barrier serum with 1.5% ectoin, a 3% ceramide complex and a 2% peptide blend. The ceramide and peptide percentages refer to ingredient blends, rather than pure ceramide or pure peptide content.
View the full ingredient list →Original studies:
- Imokawa et al. (1991), skin ceramide measurements. Original abstract reviewed.
- Spada et al. (2021), cream-and-cleanser trial. Full text, methods, outcomes and conflict disclosure reviewed.
- Gupta et al. (2023), ceramide versus paraffin trial. Original abstract reviewed.
- Ridd et al. (2022), BEE trial. Original study abstract reviewed.
- Marini et al. (2014), ectoin-cream trial. Original abstract reviewed.
Patient guidance: National Eczema Society: facial eczema; NHS: emollients; NHS: atopic eczema.
Disclosure: Published by Moumoujus, maker of The Mantle. Research and guidance checked 16 October 2026. This is general information, not a diagnosis or a substitute for your treatment plan.
